Carroll Financial Associates’s Sanofi SNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $84K | Sell |
1,666
-266
| -14% | -$13.2K | ﹤0.01% | 579 |
|
|
2021
Q3 | $93K | Buy |
1,932
+89
| +5% | +$4.53K | 0.01% | 555 |
|
|
2021
Q2 | $97K | Buy |
1,843
+84
| +5% | +$4.38K | 0.01% | 596 |
|
|
2021
Q1 | $87K | Buy |
1,759
+224
| +15% | +$10.8K | 0.01% | 605 |
|
|
2020
Q4 | $74K | Sell |
1,535
-203
| -12% | -$10K | ﹤0.01% | 587 |
|
|
2020
Q3 | $87K | Sell |
1,738
-200
| -10% | -$10.3K | 0.01% | 507 |
|
|
2020
Q2 | $98K | Buy |
1,938
+30
| +2% | +$1.46K | 0.01% | 477 |
|
|
2020
Q1 | $83K | Buy |
1,908
+135
| +8% | +$6.46K | 0.01% | 455 |
|
|
2019
Q4 | $89K | Sell |
1,773
-12
| -0.7% | -$562 | 0.01% | 529 |
|
|
2019
Q3 | $82K | Sell |
1,785
-951
| -35% | -$41K | 0.01% | 543 |
|
|
2019
Q2 | $118K | Buy |
2,736
+1,289
| +89% | +$54.8K | 0.01% | 461 |
|
|
2019
Q1 | $64K | Buy |
1,447
+1,247
| +624% | +$53.4K | 0.01% | 518 |
|
|
2018
Q4 | $8K | Hold |
200
| – | – | ﹤0.01% | 926 |
|
|
2018
Q3 | $8K | Hold |
200
| – | – | ﹤0.01% | 963 |
|
|
2018
Q2 | $8K | Hold |
200
| – | – | ﹤0.01% | 910 |
|
|
2018
Q1 | $8K | Sell |
200
-584
| -74% | -$24.3K | ﹤0.01% | 895 |
|
|
2017
Q4 | $33K | Hold |
784
| – | – | ﹤0.01% | 559 |
|
|
2017
Q3 | $39K | Hold |
784
| – | – | ﹤0.01% | 533 |
|
|
2017
Q2 | $37K | Sell |
784
-590
| -43% | -$28.2K | ﹤0.01% | 555 |
|
|
2017
Q1 | $62K | Hold |
1,374
| – | – | 0.01% | 437 |
|
|
2016
Q4 | $55K | Buy |
1,374
+310
| +29% | +$12.2K | 0.01% | 444 |
|
|
2016
Q3 | $40K | Hold |
1,064
| – | – | 0.01% | 500 |
|
|
2016
Q2 | $44K | Hold |
1,064
| – | – | 0.01% | 468 |
|
|
2016
Q1 | $42K | Sell |
1,064
-71
| -6% | -$2.85K | 0.01% | 466 |
|
|
2015
Q4 | $48K | Hold |
1,135
| – | – | 0.01% | 412 |
|
|
2015
Q3 | $55K | Buy |
1,135
+176
| +18% | +$8.96K | 0.01% | 373 |
|
|
2015
Q2 | $47K | Buy |
959
+724
| +308% | +$36.7K | 0.01% | 392 |
|
|
2015
Q1 | $12K | Sell |
235
-65
| -22% | -$3.11K | 0.01% | 501 |
|
|
2014
Q4 | $14K | Sell |
300
-511
| -63% | -$24.8K | 0.01% | 443 |
|
|
2014
Q3 | $38K | Hold |
811
| – | – | 0.01% | 354 |
|
|
2014
Q2 | $43K | Hold |
811
| – | – | 0.01% | 348 |
|
|
2014
Q1 | $42K | Hold |
811
| – | – | 0.01% | 322 |
|
|
2013
Q4 | $43K | Buy |
811
+95
| +13% | +$4.9K | 0.02% | 307 |
|
|
2013
Q3 | $36K | Buy |
+716
| New | +$36.4K | 0.01% | 335 |
|
Other funds holding SNY
CCM
Carroll Financial Associates's SNY Position: Q4 2021 in Review
Carroll Financial Associates reduced its Sanofi (SNY) stake by 14% in Q4 2021, selling an estimated $13.2K and leaving 1,666 shares worth $84K. The position accounts for ﹤0.01% of the portfolio, ranked #579.
Carroll Financial Associates first reported a position in SNY in Q3 2013 and has held it in 34 quarters since. The position peaked at $118K in Q2 2019. 625 funds tracked by Wall St. Rank hold SNY as of Q4 2021.
- Carroll Financial Associates held 1,666 shares of Sanofi worth $84K as of Q4 2021.
- Carroll Financial Associates sold 266 Sanofi shares in Q4 2021, an estimated $13.2K.
- Sanofi made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #579 holding.
- Carroll Financial Associates first reported a position in Sanofi in Q3 2013 and has held it in 34 quarters since.
- Carroll Financial Associates's Sanofi position peaked at $118K in Q2 2019.
- 625 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.
Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.